Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

Published:2014 Issue:1 Volume:12 Page:25
ISSN:1477-9560
Container-title:Thrombosis Journal
language:en
Short-container-title:Thrombosis Journal

Author:

Bauersachs Rupert M,Lensing Anthonie WA,Prins Martin H,Kubitza Dagmar,Pap Ákos F,Decousus Hervé,Beyer-Westendorf Jan,Prandoni Paolo

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Reference20 articles.

2. Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions

3. Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans

4. Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

5. Venous Thromboembolism in Patients with Renal Insufficiency: Findings from the RIETE Registry

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation in Chronic Kidney Disease;Drugs;2024-08-09

2. Efficacy and Safety of Rivaroxaban for Extremely Aged Patients with Venous Thromboembolism: A Retrospective, Cross-Sectional Real-World Study;Clinical Interventions in Aging;2024-06

3. Venous Thromboembolism in Children: The Rivaroxaban Experience;Seminars in Thrombosis and Hemostasis;2024-01-05

4. Anticoagulation in Patients with Chronic Kidney Disease;American Journal of Nephrology;2023-11-30

5. Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease;American Journal of Cardiovascular Drugs;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3